LBT Innovations : Application for quotation of securities - LBT
December 29, 2021 at 05:57 am IST
Share
Application for quotation of +securities
Announcement Summary
For personal use only
Entity name
LBT INNOVATIONS LIMITED
Announcement Type
New announcement
Date of this announcement
Wednesday December 29, 2021
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
ASX +security
Number of +securities to
code
Security description
be quoted
Issue date
LBT
ORDINARY FULLY PAID
126,003
29/12/2021
Refer to next page for full details of the announcement
Application for quotation of +securities
1 / 6
Application for quotation of +securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
LBT INNOVATIONS LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2
Registered number type
Registration number
ABN
95107670673
1.3
ASX issuer code
LBT
The announcement is New announcement
Date of this announcement
29/12/2021
Application for quotation of +securities
2 / 6
Application for quotation of +securities
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
For personal use only
Previous Appendix 3B details:
Announcement Date and
Announcement Title
Selected Appendix 3B to submit quotation
Time
request
26-Mar-2021 10:01
New - Proposed issue of Securities -
A placement or other type of issue
LBT
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
No
Application for quotation of +securities
3 / 6
Application for quotation of +securities
Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
Placement Details
only
ASX +security code and description
LBT : ORDINARY FULLY PAID
Issue date
29/12/2021
use
Distribution Schedule
Provide a distribution schedule for the new +securities according to the categories set out in the left hand column -
including the number of recipients and the total percentage of the new +securities held by the recipients in each
category.
personalFor
Total percentage of +securities held
Number of +securities held
Number of holders
For example, to enter a value of 50%
please input as 50.00
1 - 1,000
%
1,001 - 5,000
%
5,001 - 10,000
%
10,001 - 100,000
2
100.00 %
100,001 and over
%
Application for quotation of +securities
4 / 6
Application for quotation of +securities
Issue details
For personal use only
Number of +securities to be quoted
126,003
Are the +securities being issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
Shares issued in lieu of 25% gross Directors fees owing for two Directors. Approved at the Company's AGM 29 November 2021.
Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted
0.099537
Any other information the entity wishes to provide about the +securities to be quoted
Application for quotation of +securities
5 / 6
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
LBT Innovations Ltd. published this content on 28 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 December 2021 00:26:05 UTC.
LBT Innovations Limited is a medical technology company. The Company is engaged in researching, developing and commercializing technologies for the healthcare and laboratory supply markets and manufacture and sales of the Automated Plate Assessment System (APAS Independence). Its products include APAS Independence, APAS Analysis Modules, APAS-AMR Analysis Module, and APAS PharmaQ. The APAS Independence is a platform technology that automates culture-plate screening and interpretation. The APAS Analysis Modules are the intelligent image analysis software that works together with the APAS Independence to enable the screening of microbiology culture plates. The APAS-AMR Analysis Module uses artificial intelligence mage analysis platform to read and interpret antimicrobial susceptibility tests (ASTs) for the detection of antimicrobial resistance (AMR). The APAS PharmaQC provides automated imaging, analysis and interpretation of microbiology culture plates used in environmental monitoring.